Abstract
Chloroquine protein binding was determined by equilibrium dialysis of purified plasma proteins and plasma samples from 20 healthy subjects and 14 patients with rheumatoid arthritis. The mean binding was 61 +/‐ 9% in plasma from healthy subjects (range 46‐74%) and 64 +/‐ 7% in plasma from rheumatoid arthritis patients (range 55‐79%). Albumin and alpha 1‐acid glycoprotein at physiological concentrations bound chloroquine to an approximately equal extent. Protein binding is unlikely to be an important determinant of chloroquine pharmacokinetics or response. 1983 The British Pharmacological Society
| Original language | English |
|---|---|
| Pages (from-to) | 375-377 |
| Number of pages | 3 |
| Journal | British Journal of Clinical Pharmacology |
| Volume | 15 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 1983 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Characterization of chloroquine plasma protein binding in man.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver